{"url_path":"/sec/rgen/8-k/2026-05-15/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/730272/0001193125-26-225380-index.html","accession_number":"0001193125-26-225380","cik":"0000730272","ticker":"RGEN","issuer_name":"REPLIGEN CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/730272/0001193125-26-225380-index.html","primary_entity_key":"0000730272","primary_entity_name":"REPLIGEN CORP"},"word_count":384,"has_tables":true,"body_markdown":"## Item 5.07 Submission of Matters to a Vote of Security Holders\n\nOn May 14, 2026, Repligen Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). As of March 16, 2026, the record date for the 2026 Annual Meeting, 56,399,274 shares of the Company’s common stock were issued and outstanding, of which 54,022,359 shares were represented, in person or by proxy, at the 2026 Annual Meeting, constituting a quorum. At the 2026 Annual Meeting, the Company’s stockholders voted on the following proposals, which are described in detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 2, 2026:\n\ni.\nto elect the nine (9) director nominees identified in the Proxy Statement to the Company’s Board of Directors;\n\nii.\nto consider and ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026; and\n\niii.\nto consider and act upon a non-binding, advisory vote to approve the compensation of the Company’s named executive officers.\n\nEach of the director nominees in proposal 1 were duly elected by, and each of proposals 2 and 3 were approved by, the Company’s stockholders at the 2026 Annual Meeting. The following voting results are final:\n\nProposal 1 - Election of the Board of Directors\n\nNominee\n\n \n\nFor\n\n \n\n \n\nAgainst\n\n \n\n \n\nAbstain\n\n \n\n \n\nBroker Non-Votes\n\n \n\nOlivier Loeillot\n\n \n\n \n\n51,750,665\n\n \n\n \n\n \n\n116,198\n\n \n\n \n\n \n\n31,383\n\n \n\n \n\n \n\n2,124,113\n\n \n\nMartin Madaus, D.V.M., Ph.D.\n\n \n\n \n\n51,091,036\n\n \n\n \n\n \n\n775,295\n\n \n\n \n\n \n\n31,915\n\n \n\n \n\n \n\n2,124,113\n\n \n\nKaren A. Dawes\n\n \n\n \n\n42,726,647\n\n \n\n \n\n \n\n9,132,553\n\n \n\n \n\n \n\n39,046\n\n \n\n \n\n \n\n2,124,113\n\n \n\nNicolas M. Barthelemy\n\n \n\n \n\n51,526,602\n\n \n\n \n\n \n\n339,481\n\n \n\n \n\n \n\n32,163\n\n \n\n \n\n \n\n2,124,113\n\n \n\nCarrie Eglinton Manner\n\n \n\n \n\n41,987,697\n\n \n\n \n\n \n\n9,871,020\n\n \n\n \n\n \n\n39,529\n\n \n\n \n\n \n\n2,124,113\n\n \n\nKonstantin Konstantinov, Ph.D.\n\n \n\n \n\n51,137,462\n\n \n\n \n\n \n\n728,874\n\n \n\n \n\n \n\n31,910\n\n \n\n \n\n \n\n2,124,113\n\n \n\nRohin Mhatre, Ph.D.\n\n \n\n \n\n51,649,920\n\n \n\n \n\n \n\n215,384\n\n \n\n \n\n \n\n32,942\n\n \n\n \n\n \n\n2,124,113\n\n \n\nGlenn P. Muir\n\n \n\n \n\n38,592,456\n\n \n\n \n\n \n\n13,265,484\n\n \n\n \n\n \n\n40,306\n\n \n\n \n\n \n\n2,124,113\n\n \n\nMargaret A. Pax\n\n \n\n \n\n51,011,846\n\n \n\n \n\n \n\n849,103\n\n \n\n \n\n \n\n37,297\n\n \n\n \n\n \n\n2,124,113\n\n \n\nProposal 2 - Ratification of the Appointment of Independent Registered Public Accounting Firm\n\nFor\n\n \n\n \n\nAgainst\n\n \n\n \n\nAbstain\n\n \n\n \n\nBroker Non-Votes\n\n \n\n \n\n53,092,462\n\n \n\n \n\n \n\n900,084\n\n \n\n \n\n \n\n29,813\n\n \n\n \n\n \n\n—\n\n \n\nProposal 3 - Advisory Vote on Compensation of the Named Executive Officers\n\nFor\n\n \n\n \n\nAgainst\n\n \n\n \n\nAbstain\n\n \n\n \n\nBroker Non-Votes\n\n \n\n \n\n50,333,558\n\n \n\n \n\n \n\n1,513,515\n\n \n\n \n\n \n\n51,173\n\n \n\n \n\n \n\n2,124,113\n\n \n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nREPLIGEN CORPORATION\n\n \n\n \n\n \n\n \n\nDate:\n\nMay 15, 2026\n\nBy:\n\n/s/ Olivier Loeillot\n\n \n\n \n\n \n\nOlivier Loeillot\n\n \n\n \n\n \n\nPresident and Chief Executive Officer"}